South Korea · Research
Research
A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world's first "antibody biosimilar" from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.
2002
Founded
Research
Industry
South Korea
Location
106,338,684
Ranking
200 employees
Size
Get full access to view complete information
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
